VG081821AC Clinical Trials

1 actively recruiting trial

Also known as: VG081821

Pipeline

Phase 2/3: 1

Top Sponsors

Zhejiang Vimgreen Pharmaceuticals, Ltd.1

Indications

Parkinson Disease (PD)1
Parkinson's Disease1

Other1 trial

Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of VG081821AC Tablets in Patients With Early to Mid-stage Parkinson's Disease

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.